Literature DB >> 14551679

Hyperreninemic hypoaldosteronism: a possible etiological factor of septic shock-induced acute renal failure.

D du Cheyron1, A Lesage, C Daubin, M Ramakers, P Charbonneau.   

Abstract

OBJECTIVE: Hyperreninemic hypoaldosteronism has been described in critically ill patients. The present study investigated the plasma aldosterone concentration (PAC) in septic shock patients and its relationship with clinical course. DESIGN AND
SETTING: Prospective descriptive study in a medical intensive care unit (ICU) of a university hospital. PATIENTS: Forty-six consecutive patients with septic shock as defined by the ACCP/SCCM criteria. INTERVENTION: A corticotropin stimulation test, followed by treatment with low doses of hydrocortisone and fludrocortisone. MEASUREMENTS AND
RESULTS: Plasma renin activity, PAC, and cortisol levels were measured before and after the test. PAC measurements were repeated for 1 week. Relevant clinical and laboratory variables were recorded for ICU stay. Patients were divided into two groups according to PAC/renin activity ratio: above 2 (n=24 patients) and below 2 n=22). Patients with PAC/renin activity less than 2 had higher total volume of infused fluid, serum creatinine level, and fractional excretion of sodium values; aldosterone and serum creatinine were negatively correlated. Hypoaldosteronism was reversible within 1 week. Duration of ICU stay (p=0.0026) and the need for renal replacement therapy (p=0.0021) were greater in the group with PAC/renin less than 2.
CONCLUSIONS: Transient hyperreninemic hypoaldosteronism is common in patients with septic shock. These abnormal aldosterone levels are associated with greater sodium and fluid depletion and are followed by enhanced incidence of acute renal failure requiring renal replacement therapy and prolonged length of stay in ICU.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14551679     DOI: 10.1007/s00134-003-1986-6

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  34 in total

1.  Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells.

Authors:  M W Radomski; R M Palmer; S Moncada
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

Review 2.  Corticosteroid therapy in severe illness.

Authors:  S W Lamberts; H A Bruining; F H de Jong
Journal:  N Engl J Med       Date:  1997-10-30       Impact factor: 91.245

Review 3.  Acute renal failure.

Authors:  R Thadhani; M Pascual; J V Bonventre
Journal:  N Engl J Med       Date:  1996-05-30       Impact factor: 91.245

4.  Aldosterone control in critically ill patients: ACTH, metoclopramide, and atrial natriuretic peptide.

Authors:  H Raff; J W Findling
Journal:  Crit Care Med       Date:  1990-09       Impact factor: 7.598

5.  Bacteremia and severe sepsis in adults: a multicenter prospective survey in ICUs and wards of 24 hospitals. French Bacteremia-Sepsis Study Group.

Authors:  C Brun-Buisson; F Doyon; J Carlet
Journal:  Am J Respir Crit Care Med       Date:  1996-09       Impact factor: 21.405

6.  When is cortisol a mineralocorticoid?

Authors:  J Clore; A Schoolwerth; C O Watlington
Journal:  Kidney Int       Date:  1992-12       Impact factor: 10.612

7.  Plasma renin activity and plasma prorenin assays.

Authors:  J E Sealey
Journal:  Clin Chem       Date:  1991-10       Impact factor: 8.327

8.  Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock.

Authors:  Djillali Annane; Véronique Sébille; Claire Charpentier; Pierre-Edouard Bollaert; Bruno François; Jean-Michel Korach; Gilles Capellier; Yves Cohen; Elie Azoulay; Gilles Troché; Philippe Chaumet-Riffaud; Philippe Chaumet-Riffaut; Eric Bellissant
Journal:  JAMA       Date:  2002-08-21       Impact factor: 56.272

9.  Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis.

Authors:  C Brun-Buisson; F Doyon; J Carlet; P Dellamonica; F Gouin; A Lepoutre; J C Mercier; G Offenstadt; B Régnier
Journal:  JAMA       Date:  1995-09-27       Impact factor: 56.272

10.  Association of hypotension with hyperreninemic hypoaldosteronism in the critically ill patient.

Authors:  M W Davenport; R D Zipser
Journal:  Arch Intern Med       Date:  1983-04
View more
  22 in total

Review 1.  Year in review in intensive care medicine: 2003. II. Brain injury, hemodynamics, gastrointestinal tract, renal failure, metabolism, trauma, and postoperative.

Authors:  Edward Abraham; Peter Andrews; Massimo Antonelli; Laurent Brochard; Christian Brun-Buisson; Geoffrey Dobb; Jean-Yves Fagon; Johan Groeneveld; Jordi Mancebo; Philipp Metnitz; Stefano Nava; Michael Pinsky; Peter Radermacher; Marco Ranieri; Christian Richard; Robert Tasker; Benoit Vallet
Journal:  Intensive Care Med       Date:  2004-06-15       Impact factor: 17.440

2.  Low doses of fludrocortisone and hydrocortisone, alone or in combination, on vascular responsiveness to phenylephrine in healthy volunteers.

Authors:  Bruno Laviolle; Erwan Donal; Pascale Le Maguet; Fabrice Lainé; Eric Bellissant
Journal:  Br J Clin Pharmacol       Date:  2013-02       Impact factor: 4.335

3.  Etomidate and intensive care physicians.

Authors:  Roxanna Bloomfield; David Noble
Journal:  Intensive Care Med       Date:  2005-08-11       Impact factor: 17.440

4.  Relationship between early serum sodium and potassium levels and AKI severity and prognosis in oliguric AKI patients.

Authors:  Dao-Nan Chen; Jiang Du; Yun Xie; Ming Li; Rui-Lan Wang; Rui Tian
Journal:  Int Urol Nephrol       Date:  2021-01-03       Impact factor: 2.370

5.  Efficacy of selective mineralocorticoid and glucocorticoid agonists in canine septic shock.

Authors:  Caitlin W Hicks; Daniel A Sweeney; Robert L Danner; Peter Q Eichacker; Anthony F Suffredini; Jing Feng; Junfeng Sun; Ellen N Behrend; Steven B Solomon; Charles Natanson
Journal:  Crit Care Med       Date:  2012-01       Impact factor: 7.598

6.  B-Type Natriuretic Peptide, Aldosterone, and Fluid Management in ARDS.

Authors:  Matthew W Semler; Annis M Marney; Todd W Rice; Hui Nian; Chang Yu; Arthur P Wheeler; Nancy J Brown
Journal:  Chest       Date:  2016-03-23       Impact factor: 9.410

7.  Mineralocorticoid deficiency in hemorrhagic shock.

Authors:  Nikolai S Tolstoy; Majid Aized; Morgan P McMonagle; Daniel N Holena; Jose L Pascual; Seema S Sonnad; Carrie A Sims
Journal:  J Surg Res       Date:  2012-05-25       Impact factor: 2.192

8.  Clinical effects of adding fludrocortisone to a hydrocortisone-based shock protocol in hypotensive critically ill children.

Authors:  Kiran B Hebbar; Jana A Stockwell; James D Fortenberry
Journal:  Intensive Care Med       Date:  2010-12-09       Impact factor: 17.440

9.  Human and experimental septic shock are characterized by depletion of lipid droplets in the adrenals.

Authors:  Andrea Polito; Geoffroy Lorin de la Grandmaison; Arnaud Mansart; Estelle Louiset; Hervé Lefebvre; Tarek Sharshar; Djillali Annane
Journal:  Intensive Care Med       Date:  2010-07-28       Impact factor: 17.440

10.  Hyperreninemic hypoaldosteronism syndrome, plasma concentrations of interleukin-6 and outcome in critically ill patients with liver cirrhosis.

Authors:  Damien du Cheyron; Bruno Bouchet; Brigitte Cauquelin; Damien Guillotin; Michel Ramakers; Cédric Daubin; Jean-Jacques Ballet; Pierre Charbonneau
Journal:  Intensive Care Med       Date:  2007-09-29       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.